Scientific Computing World’s Post

AI is the future and AI will change everything. When this wonderful video by the The Economist was being made, the drug was in Phase IIa clinical trials. And after the video saw the light, the Phase IIa completed with >98mL increase in FVC after just 12 weeks of dosing and we observed dose-dependent response. Please enjoy this episode by the The Economist and kudos to the team and Adam Jessel 📈🧑🔬🤝🤖 #AI #Science https://lnkd.in/grG7i67D

Great to catch up with Lee Maw, Subroto Mukherjee and Bradley Quinn on how companies in the life sciences industry are driving innovation in with AI. Here’s a few of the key points that we covered; 👩🏽💻Data quality is paramount. Without accurate and reliable data, AI models cannot deliver meaningful or impactful results. ⚖️ Ethics matter. In all industries, particularly life sciences, prioritising patient safety, privacy, and fairness in AI algorithms and decision-making is crucial. 📜 Regulation is evolving. The regulatory landscape will play a critical role in determining how AI can be responsibly and effectively deployed. Life sciences is truly a unique and exciting space for AI, and I’m looking forward to seeing how progress in this area changes the way we live. 🚀 #AI #LifeSciences #DataQuality #AIethics #AIRegulation https://hubs.la/Q02N09jK0

Have you met Hiro, our AI assistant for IP and R&D? We're taking it to the next level by bridging the gap between biopharma and AI. Our newest solution is transforming scientific discovery by helping scientists unlock the potential of their data with generative AI. Tune in on July 18th to learn how Patsnap Hiro is transforming the future of drug R&D. #AI #drugdiscovery #lifesciences #innovation #AskHiro

🌍 AI News Update: November 14, 2024 🌍 Today, the global AI landscape saw significant developments that may shape the industry's future: 1️⃣ Breakthrough in AI-Driven Healthcare: New research highlights AI's potential in early-stage cancer detection, improving diagnosis accuracy and patient outcomes. With machine learning models trained on diverse datasets, this breakthrough may revolutionize diagnostic approaches. 2️⃣ AI Regulations and Policies on the Rise: As AI adoption grows, so do concerns about privacy and ethical use. Policymakers in several countries have proposed new frameworks to ensure transparent, accountable, and fair AI usage. 3️⃣ Advances in Generative AI Tools: Major tech companies unveiled updates to their generative AI platforms, focusing on increased customization and security features. This move aims to make generative AI safer and more accessible for businesses and creatives. AI is advancing rapidly, and these developments are just a glimpse of the future. Let's keep the conversation going and explore what these changes mean for industries and society! #AI #MachineLearning #Innovation #AInews #TechUpdates #FutureofAI

BIG news from RCH ... We're thrilled to announce the expansion of our #AI services, empowering #LifeSciences companies to unlock deeper insights, accelerate decision-making, and propel science forward with greater confidence. Including exciting efforts in discriminative and generative AI, our expanded suite of services will help teams access the advice and execution needed to embrace the AI revolution in the race toward their next milestone. Want the full scoop? Learn more about our expanded AI services for Life Sciences here https://lnkd.in/eVMesCK9

Join the AND Digital team on the 17th of September for a webinar on 'The Future of Life Sciences: Secrets to Successful AI Adoption'. Gain insight and practical strategies on how Life Sciences leaders can utilise AI's potential. Sign up below. Leena Pankhania Lee Maw Bradley Quinn Maisie Chang #AI #LifeSciences

🔬 Excited to share Step 2 of our "Foundations of AI Models in Drug Discovery" series! 🌟 In this installment, we dive deep into Feature Engineering and Selection in Drug Discovery, a critical step in crafting robust AI models. 🚀 From identifying essential features to optimizing model performance, we explore the nuances of this pivotal phase. 💡 #AIinDrugDiscovery #FeatureEngineering #DataScience #AI #DrugDiscovery https://lnkd.in/dzPVAPEW

Here's a simple rule in today's generative AI world: validation is the unavoidable key point on the path to success. After we bridged the intersection of the two major fields in drug discovery through AI, a big challenge arose. Once you scale up and try to utilize AI for drug discovery, you definitely need a different set of expertise. You need a group of drug hunters who can filter and analyze the results produced by AI, and make the final leap. At the center of this group is Dr. Feng Ren. Under his leadership, we have combined the best of artificial intelligence and human intelligence. In this video, we revealed the real-time demo of our biology and chemistry AI platform, which has provided a comprehensive AI-powered end-to-end solution for drug discovery. That allows essentially anyone with the tool to streamline the drug development process, reducing time and cost while increasing the success rate. #GenerativeAI #AIDrugDiscovery #DrugDiscoveryInnovation

Generative AI drives significant advancements across all major industries, including life sciences. Its versatility is helping pharma companies accelerate research and bring therapies to market faster 🚀 As a global engineering and tech consulting partner, we’ve prepared a whitepaper on how #GenerativeAI is transforming life sciences and pharma. Download it to: ✔️ Learn how to integrate generative AI into your workflows  ✔️ Understand its impact on the industry ✔️ Explore AI use cases for life science organizations ✔️ Grasp the challenges inherent to the generative AI journey 📩 https://lnkd.in/d3-se-SS   #Avenga #AvengaInsights #LifeSciences #PharmaTech #AIinHealthcare

Hello, Creatives! 👋 Excited to see you all exploring new knowledge! 🌟 🌟 Revolutionizing Healthcare with Generative AI 🌟 Generative AI is transforming the healthcare landscape, from accelerating drug discovery to enhancing diagnostics and delivering personalized care. Imagine AI crafting novel medicines, generating synthetic medical data, and assisting in early disease detection—all while improving efficiency and accessibility. 💡 Highlights from the blog: 🧬 Faster drug development with AI-driven molecular design. 🩺 Accurate diagnostics via synthetic medical imaging. 🤖 Personalized treatments tailored to individual patients. 🔒 Ethical AI solutions for privacy and inclusivity. Generative AI isn’t just a tool—it’s a game-changer for modern medicine. 🌐✨ Special thanks to Sanjit Ghosh for Guidance and Support Take your time to read the Blog #GenerativeAI #HealthcareInnovation #FutureOfMedicine